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Substantial injury can occur during reoxygenation of previously ischemic tissue in many 
experimental models, as the result of the generation of oxygen-derived free radicals. To test the 
antiradical activity of potentially protective compounds in this setting, we developed a simple 
screening system, applicable to fresh biopsy specimens, in which warm ischemia and 
reoxygenation of excised tissue are performed in vitro. Tissue production of malondialdehyde 
(MDA) equivalents is used as a nonspecific-but-sensitive marker of oxygen radical damage. Test 
compounds with putative antiradical activity are added prior to the reoxygenation phase, and 
their ability to suppress MDA production is an index of activity in preventing reoxygenation 
injury. Comparison with ischemic but not reoxygenated controls confirms the oxygen-dependent 
nature of the effect. Standard positive controls of known effective agents, such as butylated 
hydroxytoluene or deferoxamine, provide a reference for the activity of the test compound. The 
method is applicable to surgical biopsy specimens in veterinary and human medicine.  
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The term reperfusion injury refers to tissue damage observed after a period of ischemia and 
reperfusion that is manifested, not during the ischemic period, but rather during the reperfusion 
phase. Such reperfusion injury is to be distinguished from primary ischemic injury, which 
develops during the ischemic phase per se and which is halted in its progression by the 
restoration of tissue oxygenation.  
 
A major mechanism for the genesis of reperfusion injury appears to be the generation of active 
oxygen species, including superoxide radicals, (O2*)

, and hydrogen peroxide, H2O2, which can 
be converted in the presence of tissue iron to highly reactive hydroxyl radicals, HO*. (Here we 
use the symbol  *  to indicate the unpaired electron of the free radical.)  Hydroxyl radicals 
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initiate deleterious chain reactions by removing hydrogen atoms from biological substrates,  
HO* + RH  R* + H2O. In the presence of molecular oxygen, the resultant secondary radicals, 
R*, can participate in self-propagating peroxidation reactions  
 
R* + O2  ROO*  
 
ROO* + RH   ROOH + R*  
 
that amplify the injurious effects of previous ischemia at the same time that normal aerobic 
energy metabolism is being restored (McCord, 1985; Babbs, 1985; Aust et al., 1985; Bulkley, 
1983; Nayler and Elz, 1986). Polyunsaturated fatty acids are especially susceptible to 
peroxidation by such radical chain mechanisms (Tien and Aust, 1982). The resultant lipid 
hydroperoxides (ROOH) spontaneously rearrange to produce multiple degradation products, 
including easily measured malondialdehyde (MDA). MDA-like materials can also be formed as 
a result of peroxidation of sugars, proteins, and nucleic acids (Slater, 1972,1984; Bird, 1984; 
Gutteridge and Toeg, 1982), making MDA a nonspecific but sensitive marker for oxygen radical 
damage to tissues.  
 
At present, the relative susceptibilities of various tissues in various species to such reoxygenation 
injury is not well established. In particular, the relative ability of human tissues to produce free 
radicals during reoxygenation is not known. Moreover, the durations of ischemia required to set 
the stage for reperfusion injury in various tissues have not been systematically compared. 
Accordingly, there is a need for a versatile screening procedure to evaluate both the conditions 
most favoring reperfusion injury and the effects of putative anti-reperfusion injury drugs in 
tissues of many species, including man. Comparative aspects are especially important because of 
the well known differences among species in antioxidant defense systems (Fridovich, 1975,1983; 
Oberley and Oberley, 1986; Loven et al., 1980) and the large differences between tissues and 
species in the activity of superoxide-generating enzymes such as xanthine oxidase (Parks and 
Granger, 1986; Al-Khalidi and Chaglassian, 1965).  
 
Many classes of drugs may offer protection from reperfusion injury, including xanthine oxidase 
inhibitors, monoamine oxidase inhibitors, iron chelators, superoxide dismutases, copper chelates 
of salicylates, 21-amino steroids (Braughler et al., 1987), and classical chain-breaking 
antioxidants such as vitamin E. Only a few such compounds have been evaluated in the 
published literature of reperfusion injury. In most studies, the compounds were given before 
ischemia, rather than at the onset of reoxygenation, so that their efficacies in preventing 
reperfusion injury in particular, as opposed to primary ischemic injury, are not revealed.  
 
We describe a simple screening system applicable to most tissues, in which warm ischemia and 
reoxygenation of excised tissue specimens are performed in vitro, and production of 
malondialdehyde (MDA) equivalents during reoxygenation is used as a nonspecific but sensitive 
marker of oxygen radical damage. Compounds with putative antiradical activity are added prior 
to the reoxygenation phase, and the ability of test compounds to suppress MDA production is an 
index of their activity in preventing reoxygenation injury. Comparison with ischemic but not 
reoxygenated controls confirms the extent to which MDA production occurred during the 
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reoxygenation phase. Standard positive controls of known effective agents, such as butylated 
hydroxytoluene or deferoxamine, provide a reference for the activity of the test compound. 
Nonischemic controls are not required, the harvest of tissue specimens is feasible during standard 
surgical biopsy procedures, and a wide variety of experimental models.  
 
[Note: Many authors use the term “thiobarbituric acid reactive substances” (TBARS) to indicate 
that products of tissue oxidation other than malondialdehyde can cause positive reaction in the 
colorimetric assay for using thiobarbituric acid. For simplicity, we have chosen the term 







Butylated hydroxytoluene (BHT), 2-thiobarbituric acid, and TRIS buffer were obtained from 
Sigma Chemical Company (St. Louis MO, USA), trichloracetic acid from Fisher Scientific 
Company (Fair Lawn, NJ, USA), and methylene blue from Aldrich Chemical Company 
(Milwaukee, WI, USA). Deferoxamine, Lot # 30315, was kindly provided by Ciba-Geigy 
Pharmaceuticals Division (Suffern, NY, USA). The TRIS-Ringer buffer solution included 4.0 
mM KCl, 100 mM NaCl, 2.0 mM CaCl2, 40 mM TRIS, and 200 mg/dL glucose, pH 7.4. TRIS 
buffer was chosen because its solubility in the presence of calcium permitted a greater buffering 





In these initial studies, tissue samples were taken from 10 male Wistar rats anesthetized with 
sodium pentobarbital (60 mg/kg, i.p.). Liver, kidney, and heart were isolated and divided into 
five samples of approximately 0.4 g (0.2 g for heart), which were weighed and transferred to 
stoppered 50-ml Erlenmeyer flasks containing argon-saturated (anoxic) TRIS-Ringer solution. 
 
Ischemic anoxia/Reoxygenation in Short-Term Organ Culture 
 
The 50-ml Erlenmeyer flasks, containing tissue samples and 3.9 ml of argonated TRIS-Ringer 
buffer, were flushed with argon gas, restoppered, and kept in a warmed, 37°C water bath without 
shaking for 50 min to create ischemic anoxia. Mincing of the tissue and shaking were avoided at 
this stage to minimize diffusion of metabolites from the tissue into the medium that would not 
occur during ischemia in vivo. 
 
Mincing and Drug Addition 
 
After 50 min of anoxia, the tissues were minced with iris scissors into fragments approximately 1 
mm on a side. Because argon is more dense than air, its displacement from the flasks and the 
substitution of oxygen were minimal during mincing and subsequent drug addition. Then, 0.1 ml 
of TRIS Ringer buffer containing one of several antioxidant drugs to be evaluated was added to 
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achieve the desired final concentrations: deferoxamine, 100 mg/L; methylene blue, 10 mg/L; 
butylated hydroxytoluene (BHT), 150 mg/L (initially dissolved in ethanol); or nondrug-
containing control buffer. Deferoxamine was selected as a prototypic iron chelator, able to 
prevent iron catalyzed HO* production (Gutteridge et al., 1979). Methylene blue was selected as 
a xanthine oxidase inhibitor to block superoxide production by xanthine oxidase (Fridovich and 
Handler, 1962). BHT was selected as a classical antioxidant, i.e., a compound that interferes with 
radical chain propagation. These additions were made quickly to avoid introduction of oxygen. 
The flasks were restoppered, swirled gently to mix the tissues with drugs, and returned to the 




After 60 min of ischemic anoxia, the flasks were reoxygenated by vigorous bubbling of 100% 
oxygen gas into the samples for 1 min and flushing of the headspace with oxygen. (Argon gas 
was substituted for oxygen at this stage in the ischemic but not reoxygenated control 
experiments.) All flasks were then stoppered and returned to the water bath, with shaking, for 60 
min of reoxygenation at 37°C. This method is described as a “free floating” slice culture 
(Dickson and Suzangar, 1976), the tissue fragments being suspended without support in the 
medium. The surface area of the medium is approximately 12 cm
2
, and its depth is only about 3 
mm, to minimize time for equilibration of the medium with headspace gas. 
 
Thiobarbituric Acid Assay for Malodialdehyde 
 
Malondialdehyde was measured by the spectrophotometric method of Buege and Aust (1978). 
Flask contents, including tissue and buffer, were homogenized in a Teflon/glass homogenizer. 
The total homogenate was combined with 4.0 ml of TCA/TBA reagent (Buege and Aust, 1978) 
in a test tube and mixed thoroughly. Each tube was covered with a glass marble and heated for 
15 min in a water bath at 90-95°C. After cooling, the flocculent precipitate was removed by 
centrifugation at 1500 g for 5 min. The absorbance of the supernatant was determined 
spectrophotometrically at 500, 530, and 560 nm against a blank containing 4 ml of TCA/TBA 
reagent, 3.9 ml buffer, and 0.1 ml of the corresponding drug or buffer. Standard curves were 
prepared using authentic malonaldehyde (bis dimethyl acetal) [1,1,3,3-tetramethoxypropanol, 




We developed a new, more specific double derivative technique to calculate the concentration of 
MDA equivalents, which is a modification of the standard assay that eliminates most of the 
nonspecific background interference present in normal plasma or tissue samples. The 






where subscripts represent wavelengths in nanometers, A is absorbance, the constants b500 = 
A500/A530 for authentic MDA standard and b560 = A560/A530 for authentic MDA standard,  is the 






, and d is the light-path 
length through the cuvet. This relationship, derived in the Appendix, provides a measure of 
concentration based upon the 530- nm peak of genuine MDA, which is insensitive to background 
interference that does not exhibit a peak at 530 nm.  
 
For each tissue type, heart, liver, or kidney, a one-way analysis of variance (ANOVA) was 
performed to test the null hypothesis that MDA production was the same in the reoxygenated, 
ischemic-anoxic, and drug-treated tissues. The ANOVA was preceded by a Bartlett’s chi-square 
test for homogeneity of variance (Cooper, 1969). If the variances of the MDA values, y, in the 
treatment groups were not similar, a suitable transformation was found of the form,  
y = Ay/(K + y) for constants A and K, and the ANOVA performed on the transformed data 
(Anderson, 1974). Specific comparisons of the treatment groups were made using a Scheffe 





To illustrate application of the method, Figure 1 presents production of MDA equivalents in 
various postischemic tissues of the rat. Each series of bars represents a particular tissue. The first 
bar in each series represents results after 60 min of ischemia followed by 60 min of 
reoxygenation. The second bar in each series represents results obtained under identical 
experimental conditions, except for the substitution of argon for oxygen, i.e., ischemic, but not 
reoxygenated, control tissue. The remaining bars in each group represent MDA production by 
ischemic tissues reoxygenated in the presence of three prototype antiradical compounds: 
deferoxamine, methylene blue, and BHT. The effects of various treatments of MDA production 
were statistically significant for all three tissues (F > 9, p < 0.01), but much more pronounced for 
kidney and liver than for heart. In particular, all three tissues produced significantly more MDA 
with ischemia and reoxygenation than with ischemia alone, and all three tissues produced 
significantly more MDA in the absence than in the presence of the antioxidant drugs 
deferoxamine, methylene blue, and BHT (F > 12, p < 0.01).  
 
Tissue differences in oxygen radical damage, indicated by production of MDA equivalents, are 
quite striking in this system. Postischemic kidney and liver tissues produce MDA much more 
abundantly per unit weight than does cardiac muscle. MDA production is significantly inhibited 
by all three types of antiradical drugs, presumed to act by different mechanisms. Evidently, 
inhibition of superoxide production by methylene blue, chelation of iron by deferoxamine, and 
interruption of chain propagation by BHT each quench MDA production in this model. 
Parenthetically, the effects of methylene blue are not attributable to nonspecific, antioxidant 
effects, since the drug does not inhibit MDA production by liver treated by cumene 
hydroperoxide, whereas BHT, a classical chain-breaking antioxidant, does (data not shown). 
Thus, the model appears able to detect a broad spectrum of antiradical activities represented by 






FIGURE 1. Tissue malondialdehyde (MDA), as determined by the thiobarbituric acid 
method, in excised, postischemic heart, kidney, and liver of the rat. Bars represent 
mean  standard error for 10 animals. Abbreviations: o = ischemic and reoxygenated; i 
= ischemic and not reoxygenated; d = deferoxamine treated 100 mg/L in reoxygenation 
medium; m = methylene blue treated 10 mg/L in reoxygenation medium; b = BHT 






The present paper demonstrates a simple and rapid screening test for oxygen radical production 
in soft tissues, applicable to a wide variety of biopsy specimens. Differences in radical-mediated 
tissue damage, measured as postischemic production of MDA equivalents in various tissues of 
the rat, are readily apparent. Liver and kidney tissues produce abundant MDA per gram after 60 
min of ischemia; cardiac muscle produces comparatively little. The use of an ischemic but not 
reoxygenated control, rather than a nonischemic control, allows application of the technique to 
fresh biopsy specimens obtained at surgery from diverse species, including man. Tissues can be 
harvested at surgery by procedures that induce up to several minutes of warm ischemia without 
spoiling the results, since all tissues in a typical experiment are rendered ischemic for 60 min.  
 
In interpreting the results of such experiments, it is helpful to clarify the distinction between 
what White et al. have called ischemic hypoxia versus hypoxic hypoxia (White et al., 1984), as 
well as the terms reperfusion and reoxygenation. Ischemia hypoxia is hypoxia without capillary 
perfusion. Hypoxic hypoxia is hypoxia with perfusion, as can occur in asphyxiation or in 
experimental perfusion of isolated organs with oxygen poor solutions, as in the classic 
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experiments of Hearse et al. (1973). In this latter type of experiment, it is possible that continued 
clearance of carbon dioxide, extracellular potassium, etc., may create an environment different 
than that of true ischemia. Similarly, we may say that the term reperfusion refers strictly to 
reoxygenation with capillary perfusion, whereas reoxygenation may include oxygen delivery 
without capillary perfusion. 
 
The present model includes genuine ischemic hypoxia (without blood flow) at 37°C. The 
purpose of argon saturation of flasks during the ischemic phase is simply to avoid oxygen 
contamination. What is different from the natural situation is that reoxygenation is accomplished 
by diffusion from the surfaces of tissue fragments, rather than by blood perfusion. By keeping 
the diameters of the fragments less than 1 mm and the diffusion distance less than 0.5 mm, we 
hope to minimize the artificiality of this situation. One-half millimeter is the classical diffusion 
distance applied to tissue slices in organ culture, as derived theoretically and demonstrated 
practically by Trowel1 (1952). Our preliminary observation that MDA production by fresh, 
nonischemic liver tissue slices continuously oxygenated for 1 hr (3.2  2.2 nmol/g, n = 12) is 
equal to or less than that of other controls (Fig. 1) is suggestive of the adequacy of tissue 
oxygenation in this system, as does the observation of Fraga et al. (1988) that MDA production 
by 0.5-mm liver slices in response to various oxidants is compatible per cell to that obtained in 
tissue homogenates or isolated microsomes.  
 
Nevertheless, the term reoxygenation rather than reperfusion should be applied to these 
experiments, and the results should be interpreted as a model of reperfusion in short term organ 
culture (Dickson and Suzangar, 1976) rather than reperfusion itself. A corresponding advantage 
of these flask experiments, however, is that MDA-like materials are not lost from the tissue of 
origin into the circulation or perfusion medium at rates that are perfusion dependent, as would 
occur with intact animal or perfused organ experiments. 
 
In a similar sense, the present method is limited in that drug delivery to tissue is by surface 
absorption rather than via a normal capillary network. Thus, some poorly absorbed drugs may 
fail to suppress MDA production in this model, yet might still be effective in vivo. We have 
found this to be the case for allopurinol and its metabolite, oxypurinol, which gave inconsistent 
results in the present model (data not shown), but which can suppress reperfusion injury when 
given intravenously to rats and cats (Badylak et al., 1986, 1987; Parks et al., 1982; Toledo-
Pereyra, 1974). We attribute this finding to poor penetration of tissue slices by allopurinol in the 
short-term organ-culture preparations, since the more water-soluble xanthine oxidase inhibitor, 
methylene blue, did inhibit MDA production in our model. Presumably, drugs that require more 
than a few minutes to distribute to intracellular tissue compartments may show less than full 
activity when they are added to flasks after the ischemic phase. A pretreatment experiment, in 
which the drug is given to the test animal before tissue is harvested for ischemia/reoxygenation, 
may be necessary in some cases to eliminate this possibility. 
 
Other limitations of the method are related to use of the MDA assay. Although it is sensitive and 
easy to perform, the MDA assay has a number of well recognized limitations (Slater, 1972,1984; 
Bird and Draper, 1984). Foremost among these is the ability of compounds other than MDA to 
produce a positive reaction. MDA-like materials, or so-called thiobarbituric acid reactive 
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substances, are produced to varying degrees by the action of known oxygen radical generating 
systems upon biological lipids, proteins, carbohydrates, and nucleic acids (Tien and Aust, 1982; 
Slater, 1972, 1984; Bird and Draper, 1984; Gutteridge and Toeg, 1982). Most commonly, MDA 
has been used as an indicator of lipid peroxidation (Tien and Aust, 1982; Slater, 1984). In the 
present application, we do not interpret MDA as a measure of any specific radical species or the 
product of any specific radical reaction, but rather as a nonspecific, but sensitive, marker of 
abnormal oxidation of tissues. The low values obtainable in ischemic, but not reoxygenated, 
controls attest to the low levels of 530-nm-absorbing species that are not related to reoxygenation 
injury in some way. Moreover, any nonspecific interference by the commonly encountered 
yellow species that absorb around 455 nm, rather than at the 530-nm peak of authentic MDA, is 
minimized by the peak extraction technique described in the Appendix. This modification 
improves the signal-to-noise ratio of the MDA test in a manner similar to the more laborious 
methods of Satoh (1978) and Ohkawa et al. (1979), while preserving the simplicity and speed of 
the Buege and Aust method. 
 
The kinetics of MDA elimination from tissues can also complicate interpretation of some 
experiments in intact animals. MDA is largely water soluble, with a water: n-octanol partition 
coefficient of 93:7 (Esterbauer, personal communication) and so is cleared from tissues in vivo 
by the circulation, as has been readily demonstrated in isolated heart experiments (Gaudel and 
Duvelleroy, 1984) and in humans, who exhibit raised levels of MDA in the peripheral blood after 
myocardial infarction (Dousset et al., 1983; Aznar et al., 1983). In the present method, however, 
total MDA in the reoxygenation flask is measured, so that washout of the material does not 
occur. Another well recognized characteristic of MDA is its ability to cross-link with plasma 
proteins and to be otherwise metabolized (Esterbauer et al., 1982). Although some tissue 
metabolism is inevitable, we minimize this possibility by assaying the samples immediately after 
the reoxygenation period. Finally, MDA production per gram wet weight may not strictly 
correlate with relative functional impairment of various tissues after reoxygenation injury, since 
some tissues may be more resistant to free radical damage than others.  
 
Nevertheless, MDA production by ischemic and reoxygenated biopsy specimens can be used as a 
useful screening procedure for oxygen radical production to answer limited questions under 
controlled experimental conditions. As Tappel and coworkers have pointed out (Fraga et al., 
1988; Sano et al., 1986), studies of tissue slices in short-term organ culture provide a good 
compromise between biochemical and physiological systems: They maintain many aspects of 
whole-tissue organization; many organs can be studied and compared from the same animal, 
drug, ion, and oxygen concentrations can be precisely controlled; and the preparations are time 
efficient and less susceptible to manipulation errors than systems employing isolated cells or cell 
fractions. In the application presented here, we find the method to be useful, not only in 
comparing the ability of various tissues in various species to produce and be damaged by free 
radicals, but also in identifying agents capable of protecting against free-radical-mediated injury 
when it occurs.  
 
 
This work was supported by Grants HL-36712 and HL-35996 from the National Heart, Lung, and Blood Institute, 






Slope Difference Method for Peak Extraction 
 
This approach relates the concentration of a light-absorbing compound to the second derivative 
of the absorbance versus wavelength spectrum, rather than to the absolute value of absorbance. 
Consider a spectrum of absorbance, A, plotted as a function of wavelength, , and having a peak 
absorbance of interest at wavelength 2. Let wavelengths 1, 2, and 3 represent equally spaced 
points along the wavelength axis, centered on the absorbance peak at 2. Let constants b1 and b3 
represent the fractions of the peak absorbance of the authentic spectrum of a known standard 
(std) at wavelengths 1 and 3, namely Al,std  = blA2,std  and A3,std  = b3A2,std . Let  = 2  1  = 
3  2. The slope change of the true absorbance spectrum of the sample near the peak may be 




and related to concentration by substituting Beer’s Law, A2 = cd, where  is the molar 








This expression is a practical computational formula.  
 
Because concentration is calculated from the slope difference about the peak rather than the 
absolute value, it is clear (and easily shown formally) that the result is unaffected by interfering 
absorbance that is either essentially constant or linearly changing over the range 1, to 3. 
Indeed, addition of spectral interference that is nonlinear, but which exhibits three points at 
wavelengths 1, 2, and 3 that happen to fail on a straight line, will not affect the result. 
Nonspecific tissue interference, e.g., nonischemic tissue blanks or normal blood plasma blanks, 
have exactly these spectral features (low and flat without peaks). These interferences are 
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